Home  » Topic

Fda News

DR Reddy’s Shares Gain On Receiving EIR From The US FDA
Shares in Dr Reddy's gained after the company said it has received Establishment Inspection Report for its Formulations Manufacturing Plant - 3 at Bachupally, Hyderabad. "Further to our intimation dated February 28, 2020 with regard to the audit of our Formulations ...
Dr Reddy S Shares Gain On Receiving Eir From The Us Fda

Biocon Hits 52-Week High After FDA Nod for Biosimilar Cancer Drug
Biocon Ltd and Mylan N.V collaboration received an approval for their biosimilar pegfilgrastim from the American regulator FDA (US Food and Drug Administration) to sell in the US market. "Fulphila is expected to be the first biosimilar pegfilgrastim available in the ...
Biocon Hits 52 Week High After Fda Nod Biosimilar Cancer Dru
Granules India Shares Escalates By 8% Post Drug Approval
The shares of Granules India - the Hyderabad based pharmaceutical manufacturing company, surged by over 8% in the backdrop of the company receiving approval from U.S. Food and Drug Administration (FDA) to its Methylergonovine 0.2mg Tablets. Methylergonovine is a semi-synthetic ...
Granules India Shares Escalates 8 Percent Post Drug Approval
Ranbaxy sues US FDA; Stock Slips
Ranbaxy has filed a complaint against the U.S. FDA in federal court and has also asked the Court for a temporary restraining order to prevent any further action by FDA until Ranbaxy's case is decided, the company said in the press ...
Ranbaxy Sues Us Fda Stock Slips
Ranbaxy gets FDA nod to sell generic Diovan tablets in US
Drug major Ranbaxy Laboratories has received US health regulator's approval to market generic version of Novartis' Diovan tablets, used for treating high blood pressure and heart failure, in the US market with 180-days of marketing exclusivity. Ohm Laboratories Inc, a ...
Ranbaxy shares slide 23% as FDA issues import alert
Shares in Ranbaxy fell as much 23% in early trade as the Food and Drug Administration in the US issued an import alert for the company's facilities in Mohali. The stock was last trading at Rs 348, down Rs 104 ...
Ranbaxy Shares Slide 23 As Fda Issues Import Alert
Get Instant News Updates
Notification Settings X
Time Settings
Clear Notification X
Do you want to clear all the notifications from your inbox?
Settings X